Skip to content
WorkingMomRx
Menu

Evidence review

How to Get a GLP-1 Without Insurance (Fast and Cheap)

No coverage? You can still start a GLP-1: the practical cash-pay routes, compounded vs brand, and what a month actually costs.

By Dana Whitfield, Managing Editora working mom, not a treating clinicianevery figure cited to its source
On this page

The short version

You do not need insurance to start a GLP-1. The fastest, cheapest route is a cash-pay telehealth program: an async questionnaire, a flat or low monthly price, and shipping to your door — no claim, no prior authorization, no coverage denial to appeal. Most people without coverage go the compounded-semaglutide route because the cash price is far below brand-name Ozempic or Wegovy. Below are the real routes, honest costs, and the trade-offs. This guide is educational only and not medical advice.

Why "without insurance" is often the faster path

Counterintuitively, skipping insurance can be quicker. A covered brand prescription frequently means a prior authorization, a step-therapy hoop, and weeks of back-and-forth before anyone ships anything. A cash-pay telehealth start skips all of it: you pay a flat monthly price and the process is a straight line. If you've been denied coverage or your plan excludes weight-loss drugs entirely, cash-pay isn't a downgrade — it's usually the shorter road.

The three routes, cheapest to priciest

Three real doors, and the price gap between the first and the third is roughly tenfold. Dollar figures are what the providers we track disclosed at our last review — confirm the current number before you pay.

RouteCash price, as last verifiedThe trade-off
Compounded semaglutide or tirzepatide via cash-pay telehealthFlat plans run $99–$399/mo across our roster; intro rates advertise as low as $49/mo without publishing what you pay afterwardsCompounded drugs are not FDA-approved and are not reviewed for safety, effectiveness or quality4
Brand-name self-pay through a manufacturer or pharmacy channel$349/mo ongoing for Wegovy or Ozempic, $299–$449 for Zepbound vials by dose, on the one marketplace we track that offers itA scheduled video visit is required, and the medication is billed separately from the program fee
Brand-name pens at cash priceFrom $705/mo up to about $1,299/mo across the brand rows on our roster; pens are quoted around $1,080–$1,200The priciest door by a wide margin — but it is the on-label, FDA-approved product

Most uninsured patients land in the first row, because posted compounded prices run a small fraction of brand list prices. It is legitimate work when a properly licensed pharmacy does it, but read is compounded semaglutide online legit and safe? before you buy — the caveats in the third column are not a formality.

There's also a middle door worth naming: brand-only self-pay, where you skip compounding entirely but still don't route through insurance. 9amHealth prices this as one $149/mo membership (free if your insurance does cover it) that folds in specialist visits, labs and devices alongside brand Wegovy, Zepbound or Saxenda — though it publishes no state list at all. The Virtual NP prices it two ways instead: a $99 pay-as-you-go visit with zero ongoing commitment, or a $75/mo membership, either way for brand Zepbound or Wegovy "from Eli Lilly or Novo Nordisk" — with HSA/FSA accepted, in a seven-state footprint (TX, FL, NY, AZ, NV, NM, KS). Neither itemizes what the medication itself costs beyond the visit or membership fee, so budget that as a separate, unconfirmed line item.

What a month actually costs

Cash prices move constantly, so treat these as ranges, not quotes. Compounded semaglutide through budget telehealth typically starts low — often around or under a hundred dollars for an introductory tier — then may step up as your dose climbs on tiered plans. Flat-price programs cost more per month up front but don't surprise you during titration. Brand-name cash pricing is a different tier entirely, generally many hundreds to over a thousand dollars a month depending on the drug and any manufacturer program. The cheapest sticker isn't always the cheapest year: a tier that doubles at a higher dose can beat a flat plan on month one and lose by month four. We break the math down in flat price vs dose-scaling GLP-1 pricing and rank the value picks in cheapest GLP-1.

Compounded vs brand: the honest trade-off

Compounded wins on price and speed; brand wins on regulatory standing. Compounded drugs are not FDA-approved and are not reviewed for safety, effectiveness, or quality the way approved products are — the FDA has flagged concerns specifically about compounded semaglutide4, and dosing and administration errors with compounded semaglutide have been reported to poison control centers5. That doesn't make compounding illegitimate — it's a long-standing, regulated practice — but it does mean the pharmacy's licensing and your own dosing discipline matter more. If you go compounded, use a program that routes to a properly licensed pharmacy and gives you clear dosing instructions. LIV by WellNow is a rare case that says this part plainly on its own site: "compounded semaglutide is not approved or evaluated for safety, efficacy, or quality by FDA," printed next to a flat $279/mo all-inclusive price — a good-faith disclosure most competitors skip.

The efficiency route, step by step

  1. Pick a cash-pay, async provider — no video visit, no coverage check. Flat pricing keeps the math honest through titration.
  1. Complete the written questionnaire (ten to fifteen minutes) and upload what they ask for.
  1. Let a licensed clinician review and prescribe. Pay the flat monthly price; the pharmacy fills and ships.
  1. Reassess at your next dose step — that's when tiered plans get expensive, so know your number before you titrate.

The medicine works regardless of who pays

Paying cash doesn't change the evidence. The molecules deliver roughly 15% mean weight loss with semaglutide1 and around 20% with tirzepatide2 in the large obesity trials, and semaglutide also reduced cardiovascular events in adults with obesity and established heart disease3 — all under clinician supervision. Needle-averse? There's now a once-daily oral semaglutide shown effective for weight loss in a large trial6. Whichever route you pick, a real clinician should still be reviewing your case.

Where to start

Confirm the current price on the provider's page, finish the questionnaire, and you're moving.

Frequently asked questions

Can I get a GLP-1 without insurance?

Yes. Cash-pay telehealth programs prescribe GLP-1s without any coverage. You pay a flat or tiered monthly price directly — no claim, no prior authorization, no denial to appeal.

What's the cheapest way to get a GLP-1 without insurance?

Compounded semaglutide through a budget cash-pay program is usually the lowest starting price, often around or under a hundred dollars for an introductory tier. Watch for tiered pricing that climbs as your dose increases, and confirm the pharmacy is properly licensed.

Is compounded semaglutide safe if I'm paying cash?

It can be, from a properly licensed pharmacy, but compounded drugs are not FDA-approved and dosing errors have been reported. Use a program with clinician oversight and clear dosing instructions, and read up on the compounding rules before you buy.

Where this leaves you

References

  1. Wilding JPH, Batterham RL, Calanna S, et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). New England Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/33567185/
  2. Jastreboff AM, Aronne LJ, Ahmad NN, et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). New England Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/35658024/
  3. Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. (2023). Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT). New England Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/37952131/
  4. U.S. Food and Drug Administration (2025). Medications Containing Semaglutide Marketed for Type 2 Diabetes or Weight Loss. FDA Drug Safety Information. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/medications-containing-semaglutide-marketed-type-2-diabetes-or-weight-loss
  5. Lambson JE, Flegal SC, Johnson AR. (2023). Administration errors of compounded semaglutide reported to a poison control center. Journal of the American Pharmacists Association. https://pubmed.ncbi.nlm.nih.gov/37392810/
  6. Knop FK, Aroda VR, do Vale RD, et al. (2023). Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1). Lancet. https://pubmed.ncbi.nlm.nih.gov/37385278/

Read this as information, not instructions. WorkingMomRx is educational and never a diagnosis, a treatment plan, or a reason to start or stop a medication. A GLP-1 is a clinical decision — run it past a licensed clinician who knows your history before you act on anything here.